𝔖 Bobbio Scriptorium
✦   LIBER   ✦

von Hippel-Lindau Gene Status and Response to Vascular Endothelial Growth Factor Targeted Therapy for Metastatic Clear Cell Renal Cell Carcinoma

✍ Scribed by Choueiri, Toni K.; Vaziri, Susan A.J.; Jaeger, Erich; Elson, Paul; Wood, Laura; Bhalla, Ish Prasad; Small, Eric J.; Weinberg, Vivian; Sein, Nancy; Simko, Jeff; Golshayan, Ali-Reza; Sercia, Linda; Zhou, Ming; Waldman, Frederic M.; Rini, Brian I.; Bukowski, Ronald M.; Ganapathi, Ram

Book ID
122470663
Publisher
Lippincott Williams and Wilkins
Year
2008
Tongue
English
Weight
592 KB
Volume
180
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical factors associated with outcome
Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy
✍ Toni K. Choueiri; Jorge A. Garcia; Paul Elson; Mohamad Khasawneh; Saif Usman; Al πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Therapy targeted against the vascular endothelial growth factor (VEGF) pathway is a standard of care for patients with metastatic renal cell carcinoma (RCC). The identification of patients who are more likely to benefit from these agents is warranted. ## METHODS. In to

Vascular endothelial growth factor overe
Vascular endothelial growth factor overexpression is correlated with von Hippel-Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinoma
✍ Hiroshi Igarashi; Mariko Esumi; Hajime Ishida; Kiyoki Okada πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 272 KB πŸ‘ 1 views

## Abstract ## BACKGROUND A high frequency of genetic alterations of the von Hippel‐Lindau (__VHL)__ gene and overexpression of the vascular endothelial growth factor (__VEGF)__ gene have been observed independently in human sporadic renal cell carcinoma (RCCs), but to the authors' knowledge the a